Coincidently, GBM-resected specimens have previously been shown to produce CCL2 and CCL22, both of which are chemokines that attract CCR4-expressing Treg (Sebastiani et al., 2001; Jordan et al., 2008). This evidence concerns the gene CCL22 and glioblastoma.